Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Type of study
Language
Publication year range
1.
Biol Blood Marrow Transplant ; 14(3): 290-300, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18275895

ABSTRACT

Because natural killer (NK) cells can be potent anti-tumor effectors after allogeneic stem cell transplantation, we investigated NK reconstitution and receptor expression in patients undergoing allogeneic hematopoietic stem cell transplantation, focusing on the activating receptors that trigger anti-tumor responses. We determined that NK levels in the peri-transplant period were inversely proportional to the dramatic rise and fall in plasma levels of the NK homeostatic cytokine IL-15, which increased more than 50-fold from pretreatment to the day of transplant during the lymphoreductive preparative regimen. Furthermore, in NK cells cultured with IL-15, we observed an up-regulation of the activating receptors NKG2D, NKp30, and NKp46, associated with an increase in anti-tumor lytic activity. Similarly, the expression of these activating receptors increased significantly during the early post-transplant period, concurrent with a rapid increase in total NK cells and a shift toward increased expression of CD56. These data suggest that the cytokine milieu of transplants, in particular elevated levels of IL-15, may contribute to anti-tumor efficacy post-transplant by enhancing the recovery of NK subsets and modulating expression of activating receptors.


Subject(s)
Graft vs Leukemia Effect/immunology , Hematopoietic Stem Cell Transplantation , Interleukin-15/immunology , Killer Cells, Natural/immunology , Receptors, Immunologic/immunology , Adult , Aged , CD56 Antigen/biosynthesis , CD56 Antigen/immunology , Cells, Cultured , Female , Graft vs Leukemia Effect/drug effects , Humans , Interleukin-15/blood , Interleukin-15/pharmacology , Killer Cells, Natural/metabolism , Killer Cells, Natural/pathology , Lymphocyte Depletion , Lymphoproliferative Disorders/blood , Lymphoproliferative Disorders/immunology , Lymphoproliferative Disorders/pathology , Lymphoproliferative Disorders/therapy , Male , Middle Aged , Myelodysplastic Syndromes/blood , Myelodysplastic Syndromes/immunology , Myelodysplastic Syndromes/pathology , Myelodysplastic Syndromes/therapy , NK Cell Lectin-Like Receptor Subfamily K , Natural Cytotoxicity Triggering Receptor 1 , Natural Cytotoxicity Triggering Receptor 3 , Primary Myelofibrosis/blood , Primary Myelofibrosis/immunology , Primary Myelofibrosis/pathology , Primary Myelofibrosis/therapy , Receptors, Immunologic/biosynthesis , Receptors, Natural Killer Cell , Transplantation, Homologous , Up-Regulation/drug effects , Up-Regulation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...